| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 04/23/2008 | CN101166515A Production of emulsions for intravenous injection of water-insoluble pharmaceutical compositions |
| 04/23/2008 | CN101165071A Clexane and preparation method thereof |
| 04/23/2008 | CN101165036A Ether compounds, compositions, and uses thereof |
| 04/23/2008 | CN101164562A Traditional Chinese medicine historical preparation for treating apoplexy |
| 04/23/2008 | CN101164547A Application of pennogenin in preparing hemostatic medicines |
| 04/23/2008 | CN101164543A Acyl pseudopeptides bearing a functionalised auxiliary spacer |
| 04/23/2008 | CN100383163C Antibody for inhibiting blood coagulation and method of use thereof |
| 04/23/2008 | CN100383139C Piperidine-2,6-dione derivatives capable of inhibiting cell from releasing tumor necrosis factor |
| 04/23/2008 | CN100383132C Azoles as malonyl-COA decarboxylase inhibitors useful as metabolic modulators |
| 04/22/2008 | US7361748 Protease for identifying modulators for treatment and prevention of thrombocytopenia and liver disorders |
| 04/22/2008 | US7361738 Novel protein factors which share homologous sequences and biological activities with megakaryocyte colony-stimulating factor (meg-CSF); treatment of deficiency of platelets |
| 04/22/2008 | US7361676 Solid preparation containing single crystal form |
| 04/22/2008 | US7361669 particularly useful for treating cardiovascular disease |
| 04/22/2008 | US7361658 2-acylaminothiazole derivative or salt thereof |
| 04/22/2008 | US7361639 Gene therapy agent for Haemophilia B and its preparation method |
| 04/22/2008 | US7361638 Pharmaceutical combination for the treatment of tissue damage owing to an arterial irrigation defect |
| 04/22/2008 | US7361345 monoclonal antibody prevents the growth or differentiation of the B cell; secreted by the hybridoma; therapy of autoimmune diseases, sytematic lupus erythematosus, primary biliary cirrhosis, and idiopathic thrombocytopenic purpura; biodrug |
| 04/17/2008 | WO2008046084A2 Spiroheterocyclic compounds and their uses as therapeutic agents |
| 04/17/2008 | WO2008045566A1 Methods for dosing an orally active 1,2,4-oxadiazole for nonsense mutation suppression therapy |
| 04/17/2008 | WO2008045410A2 Alcohol free formulation of argatroban |
| 04/17/2008 | WO2008044785A1 Material for improvement of cerebral blood flow, and use thereof |
| 04/17/2008 | WO2008044767A1 Aromatic amine derivative and use thereof |
| 04/17/2008 | WO2008044731A1 N-phenyloxamidic acid derivative |
| 04/17/2008 | WO2008044729A1 Carboxylic acid derivative |
| 04/17/2008 | WO2008044631A1 Therapeutic and/or ameliorating agent for disseminated intravascular coagulation |
| 04/17/2008 | WO2008044337A1 γ-GLOBIN INDUCER |
| 04/17/2008 | WO2008043759A1 Physiologically acceptable salts of 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1h-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionic acid ethyl ester |
| 04/17/2008 | US20080091263 Apparatus and Methods for Preventing or Treating Failure of Hemodialysis Vascular Access and Other Vascular Grafts |
| 04/17/2008 | US20080091010 Induce the biosynthesis of cytokines such as interferon and tumor necrosis factor; antiviral and antitumor agents |
| 04/17/2008 | US20080090996 Thrombopoietin mimetics |
| 04/17/2008 | US20080090870 Use of 2-(amino-substituted piperidin-1-yl)benzimidazoles as antidiabetic agents, or to treat carbohydrate and lipid metabolic disorders; use in combination with other drugs; N-[2-(3-Aminopiperidin-1-yl)-1-(3-methylbut-2-enyl)-1H-benzimidazol-6-yl]-benzenesulfonamide or salts for example |
| 04/17/2008 | US20080090858 Condensed indoline derivatives and their use as 5HT, in particular 5HT2C, receptor ligands |
| 04/17/2008 | US20080090857 Statin derivatives |
| 04/17/2008 | US20080090842 Novel pyridyl cyanoguanidine compounds |
| 04/17/2008 | US20080090829 5-{2-[2-(4-Tert-Butyl- phenyl)-oxazol-4-yl]-ethylsulfamoyl}-2-methyl-benzoic acid methyl ester; used as peroxisome proliferator activator receptor agonist, to increase high density lipoproteins and lower LDL-cholesterol and triglycerides; treatment of atherosclerosis, cardiovascular, metabolic disorders |
| 04/17/2008 | US20080090815 Anticoagulates for treating cardiovascular disorders, such as myocardial infarct, angina pectoris, restenoses after angioplasty, bypass, stroke; treatment of atherosclerosis, arthritis, Alzheimer's disease or cancer |
| 04/17/2008 | US20080090807 Lactam-containing compounds and derivatives thereof as factor xa inhibitors |
| 04/17/2008 | US20080090803 Fatty alcohol drug conjugates |
| 04/17/2008 | US20080090800 Mandelic acid derivatives and their use as thrombin inhibitors |
| 04/17/2008 | US20080090797 tert-Butyl[3-(4-phenyloxazolidin-2-on-3-yl)-4-(2-styryl)azetidin-2-on-1-yl]acetate; known as synthetic intermediates for the preparation of beta -lactam antibiotics; diuretic |
| 04/17/2008 | US20080090792 Selective glucocorticoid receptor agonists |
| 04/17/2008 | US20080090787 Thrombopoietin mimetics |
| 04/17/2008 | US20080090756 Somatostatin agonists |
| 04/17/2008 | US20080090755 Follistatin Variant Polypeptide |
| 04/17/2008 | US20080089997 Partially Defatted Cocoa Solids Containing Conserved Amounts of Cocoa Polyphenols |
| 04/17/2008 | US20080089948 Method of use for lanthanum carbonate and lanthanum hydroxycarbonate |
| 04/17/2008 | US20080089941 Fucoidan compositions and methods |
| 04/17/2008 | US20080089938 Compositions and methods for polynucleotide delivery |
| 04/17/2008 | DE102006048042A1 Acylaminoimidazole und Acylaminothiazole Acylaminoimidazole and Acylaminothiazole |
| 04/17/2008 | CA2675518A1 Methods for dosing an orally active 1,2,4-oxadiazole for nonsense mutation suppression therapy |
| 04/17/2008 | CA2666396A1 Physiologically acceptable salts of 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1h-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionic acid ethyl ester |
| 04/17/2008 | CA2666177A1 Acylaminoimidazoles and acylaminothiazoles |
| 04/17/2008 | CA2665691A1 Agent for therapy and/or improvement of disseminated intravascular coagulation |
| 04/16/2008 | EP1911837A2 FAD4, FAD5, FAD5-2, and FAD6, fatty acid desaturase family members and uses thereof |
| 04/16/2008 | EP1911754A1 Dipeptidyl peptidase inhibitors |
| 04/16/2008 | EP1911743A1 Cyclic amine compound |
| 04/16/2008 | EP1911459A1 Lymphangiogenesis promoter |
| 04/16/2008 | EP1910420A2 Human inhibitory anti-factor viii antibodies binding to the a2 domain |
| 04/16/2008 | EP1910380A1 Oxazolopyridine derivatives as sirtuin modulators |
| 04/16/2008 | EP1910345A1 Substituted amides, their preparation and their use as pharmaceuticals |
| 04/16/2008 | EP1910295A1 Substituted pyridocarboxamides as inhibitors of plasminogen activator inhibitor 1 (pai-1) |
| 04/16/2008 | EP1909910A1 Benzimidazole derivatives as sirtuin modulators |
| 04/16/2008 | EP1909817A2 Use of the globular domain of acrp30 for the preparation of a medicament for the prevention and/or treatment of thrombosis-related diseases |
| 04/16/2008 | EP1909802A2 Steroidal glycoside compounds as core 2 glcnac-t inhibitors |
| 04/16/2008 | EP1423382B1 Pyrazole-derived kinase inhibitors and uses thereof |
| 04/16/2008 | EP1343823B1 Antithrombotic von willebrand factor (vwf) collagen bridging blockers |
| 04/16/2008 | EP1250155B1 Angiogenesis and vascular permeability modulators and inhibitors |
| 04/16/2008 | EP1108039B1 Elongase genes and uses thereof |
| 04/16/2008 | CN101163700A 三胺衍生物 Triamine derivative |
| 04/16/2008 | CN101163497A Use of erythrocytes containing arginine deiminase for preparing a drug to decrease the in vivo plasma concentration of arginine |
| 04/16/2008 | CN101163496A Tropoelastin for promoting endothelial cell adhesion or migration |
| 04/16/2008 | CN101163490A Artificial cerebrospinal fluid |
| 04/16/2008 | CN101163469A 腹膜透析液 Peritoneal dialysate |
| 04/16/2008 | CN101161641A Tricyclic steroid hormone nuclear receptor modulators |
| 04/16/2008 | CN101161282A Blood circulation promoting nourishing kidney health preserving electric girdle |
| 04/16/2008 | CN101161269A Pharmaceutical composition of cattail pollen or its extract and hawkthorn leaf or its extract |
| 04/16/2008 | CN101161265A Medicament taken orally for treating aplastic anemia |
| 04/16/2008 | CN101161264A A Chinese medicine preparation for easing-off head and neck neoplasm radiotheraphy secondary reaction |
| 04/16/2008 | CN101161091A An antierythrite chewing gum |
| 04/16/2008 | CN100381462C Peptides and medicinal compositions containing the same |
| 04/16/2008 | CN100381454C Crystalline form of a ribofuranosyluronamide derivative: a human adenosine a2a receptor agonist |
| 04/16/2008 | CN100381442C Method for producing by stereospecific hydration tetrahydropterins and optically pure derivatives, in particular tetrahydrofolic acid and its optically pure derivatives |
| 04/16/2008 | CN100381168C Use of glucoprotein for pharmaceuticals |
| 04/16/2008 | CA2567394A1 Glycoprotein vi antibodies and methods of use thereof |
| 04/15/2008 | US7358354 Administering genetically engineered vectors to modulate lymphocytes; transfecting macrophages; used for prophylaxis or treatments for cancers or immune-related disorders |
| 04/15/2008 | US7358338 Heme peptide |
| 04/15/2008 | US7358333 Polypeptides of the IFNα-5 gene |
| 04/15/2008 | US7358273 For therapy of inflammatory diseases, autoimmune diseases, destructive bone disorders, proliferative disorders, infectious diseases, and degenerative diseases |
| 04/15/2008 | US7358257 sulfonylurea derivatives, sulfonylthiourea derivatives, sulfonylguanidine derivatives, sulfonylcyanoguanidine derivatives, thioacylsulfonamide derivatives, and acylsulfonamide derivatives; effective for prevention and treatment of cardiovascular diseases, antithrombotic agents |
| 04/15/2008 | US7357924 Nucleic acids/proteins/antibodies/mimetics for cell differentiation/prolilferation control |
| 04/15/2008 | US7357897 Blood processing systems and methods that alternate flow of blood component and additive solution through an in-line leukofilter |
| 04/15/2008 | CA2411468C Thrombopoietin mimetics |
| 04/15/2008 | CA2410303C Beta-amino acid nitrile derivatives |
| 04/15/2008 | CA2105888C Use of a direct thrombin inhibitor in the production of a drug presenting a thrombolytic activity |
| 04/10/2008 | WO2008041131A2 Anticoagulant compounds |
| 04/10/2008 | WO2007120767A3 Agonist erythropoietin receptor antibodies |
| 04/10/2008 | WO2007092469A3 Combination of organic compounds |
| 04/10/2008 | US20080085919 1H-Pyrazoles Useful In Therapy |
| 04/10/2008 | US20080085863 Method and Composition for Treating a Fibrotic Disorder |
| 04/10/2008 | US20080085861 Gas1 polypeptides |